Ruth Chepngetich Suspended After Positive Drug Test for Banned Diuretic
Kenya’s marathon world record-holder, Ruth Chepngetich, has been provisionally suspended after testing positive for a banned substance, the Athletics Integrity Unit (AIU) announced.
Chepngetich made history in October 2024 when she became the first woman to break the 2:10 barrier, clocking a record time of 2:09:56 at the Chicago Marathon.
However, the AIU revealed that a sample collected on March 14 tested positive for Hydrochlorothiazide, a diuretic commonly used to treat fluid retention and high blood pressure.
According to the AIU, the banned substance was detected at a concentration of 3,800 ng/mL — well above the 20 ng/mL threshold considered negative.
Hydrochlorothiazide is listed as a “Specified Substance” under World Anti-Doping Agency rules and carries a standard ban of two years.
AIU Head Brett Clothier stated that Chepngetich was first notified in person on April 16. She voluntarily accepted a provisional suspension on April 19 while the investigation continued.
A formal Notice of Charge was issued on Thursday, along with an official suspension.
Chepngetich, a three-time Chicago Marathon winner and 2019 World Champion, now awaits a disciplinary hearing and retains the right to defend her case before a tribunal.
The AIU confirmed it will not provide further comment until the case is concluded.
You may be interested

Manchester Rivals Face Off in Youth Cup Final Amid Stadium Controversy
gisthub - May 14, 2026The FA Youth Cup, a competition running since 1952, reaches its climax as Manchester City and Manchester United clash for the title. This…

Police Apprehend Man for Orchestrating Fake Job Scam Against Kano Students
gisthub - May 14, 2026Richard Peter, a 32-year-old resident of Lagos, is currently detained by Zone One police headquarters in Kano. Authorities arrested the suspect following allegations…

Polycystic Ovary Syndrome Rebranded to Polyendocrine Metabolic Ovarian Syndrome
gisthub - May 14, 2026A global coalition of medical professionals and patient advocates has officially renamed Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This shift,…
Most from this category












Leave a Comment